Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:44 AM
Ignite Modification Date:
2025-12-25 @ 12:44 AM
NCT ID:
NCT01261767
Eligibility Criteria:
Inclusion Criteria:
* Subjects with moderate to severe stable chronic plaque psoriasis for at least 6 months, with or without psoriatic arthritis
* Affected body surface area (BSA) greater than or equal to 15%
* Physician's Global Assessment (PGA) score of 3 or more
* Female subjects of non-childbearing potential or postmenopausal for at least 1 year. Male subjects must agree to use effective method of birth control
* Body Mass Index (BMI) less than or equal to 38.0 kg/m2
Exclusion Criteria:
* Concomitant anti-psoriatic treatment
* Infectious disease requiring systemic anti-infectious treatment within the 2 weeks prior to administration of trial drug
* Known history of Human Immunodeficiency Virus (HIV)
* Hepatitis B and/or C (determined by test)
* Live virus or bacteria vaccines within the last month before drug administration
* Known active herpes/herpes zoster/cold sores
* Kidney insufficiency
* Liver insufficiency
* Lymphoproliferative disease
* History or signs of malignancy within the last 5 years
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT01261767
Study Brief:
Protocol Section:
NCT01261767